Kaizaki-Mitsumoto, A; Noguchi, N; Yamaguchi, S; Odanaka, Y; Matsubayashi, S; Kumamoto, H; Fukuhara, K; Funada, M; Wada, K; Numazawa, S. Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market Forensic Toxicol., 1 Jan 2016, 34 (1), 108–114. 854 kB. https://doi.org/10.1007/s11419-015-0293-6 #5 MS,NMR
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Heim, R; Pertz, HH; Elz, S. Preparation and in-vitro pharmacology of novel secondary amine-type 5-HT2A-receptor agonists: From submillimolar to subnanomolar activity Arch. Pharm. Pharm. Med. Chem., , 331 (Suppl. 1), 34. 493 kB. #2 Poster abstract
Heim, R; Pertz, HH; Elz, MZS. Stereoselective synthesis, absolute configuration and 5-HT2A-receptor agonism of chiral 2-methoxybenzylamines Arch. Pharm. Pharm. Med. Chem., , 335 (Suppl. 1), 82. 573 kB. #1 Poster abstract
Elz, S; Kläß, T; Heim, R; Warnke, U; Pertz, HH. Development of highly potent partial agonists and chiral antagonists as tools for the study of 5-HT2A-receptor mediated functions N-S. Arch. Pharmacol., , 365 (Suppl. 1), R29. 630 kB. #3
Silva, ME. Theoretical study of the interaction of agonists with the 5-HT2A receptor Ph. D. Thesis, Universität Regensburg, Regensburg, Germany, 26 Aug 2008. 5.9 MB. #169
Heim, R; Pertz, H; Walther, I; Elz, S. Congeners of 3-(2-benzylaminoethyl)-2,4-quinazolinedione: Partial agonists for rat vascular 5-HT2A receptors N-S. Arch. Pharmacol., , 358 (Suppl. 1), R105. 575 kB. #2
Silva, ME; Heim, R; Strasser, A; Elz, S; Dove, S. Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor J. Comput. Aided Mol. Des., 1 Jan 2011, 25 (1), 51–66. 834 kB. https://doi.org/10.1007/s10822-010-9400-2 #47